• Society of Nuclear Medicine. Procedure guideline for gallium scintigraphy in inflammation. Version 3.0. Reston (VA): Society of Nuclear Medicine; 2004 Jun 2. 5 p.

This is the current release of the guideline.

This guideline updates a previous version: Society of Nuclear Medicine. Procedure guideline for gallium scintigraphy in inflammation, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 21 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

Background Information and Definitions

⁶⁷Gallium (⁶⁷Ga) scintigraphy may include regional, whole-body, planar, and single-photon emission computed tomographic (SPECT) scintigrams, or any combination performed after intravenous injection of ⁶⁷Ga-citrate.

Examples of Clinical or Research Applications

1. Whole-body survey to localize source of fever in patients with fever of unknown origin (FUO)
2. Detection of pulmonary and mediastinal inflammation/infection, especially in the immunocompromised patient
3. Evaluation and follow-up of active lymphocytic or granulomatous inflammatory processes, such as sarcoidosis or tuberculosis
4. Diagnosing osteomyelitis and/or disk space infection. ⁶⁷Ga is preferred over labeled leukocytes for disk space infection and vertebral osteomyelitis
5. Diagnosis and follow-up of medical treatment of retroperitoneal fibrosis
6. Evaluation and follow-up of drug-induced pulmonary toxicity (e.g., bleomycin, amiodarone)

Procedure

The detailed procedure recommendations in the guideline address the following areas: patient preparation; information pertinent to performing the procedure (i.e., important data that the physician should have about the patient at the time the exam is performed and interpreted); precautions; information regarding the radiopharmaceutical (i.e., ranges of administered activity, organ receiving the largest radiation dose, effective dose), image acquisition; interventions; processing; interpretation/reporting; quality control, and sources of error.

None provided

The type of evidence supporting the recommendations is not specifically stated.

• Society of Nuclear Medicine. Procedure guideline for gallium scintigraphy in inflammation. Version 3.0. Reston (VA): Society of Nuclear Medicine; 2004 Jun 2. 5 p.

Not applicable: The guideline was not adapted from another source.

1999 Feb (revised 2004 Jun 2)

Society of Nuclear Medicine, Inc - Medical Specialty Society

Society of Nuclear Medicine (SNM)

Task Force

Authors: Christopher J. Palestro, MD (Long Island Jewish Medical Center, New Hyde Park, NY); Manuel L. Brown, MD (Henry Ford Hospital, Detroit, MI); Lee A. Forstrom, MD, PhD (Mayo Clinic, Rochester, MN); Bennett S. Greenspan, MD (Harry S. Truman VA Medical Center, Columbia, MO); John G. McAfee, MD (George Washington Hospital, Washington, DC); Henry D. Royal, MD (Mallinckrodt Institute of Radiology, St. Louis, MO); Donald S. Schauwecker, PhD, MD (Richard L. Roudebush VA Medical Center, Indianapolis, IN); James E. Seabold, MD (Carl T. Hayden VA Medical Center, Phoenix, AZ); Alberto Signore, MD (University La Sapienza, Rome, Italy)

Not stated

This is the current release of the guideline.

This guideline updates a previous version: Society of Nuclear Medicine. Procedure guideline for gallium scintigraphy in inflammation, 2.0. Reston (VA): Society of Nuclear Medicine; 1999 Feb. 21 p. (Society of Nuclear Medicine procedure guidelines; no. 2.0).

None available

This summary was completed by ECRI on July 20, 1999. It was verified by the guideline developer as of August 5, 1999. This summary was updated by ECRI on May 18, 2005. The updated information was verified by the guideline developer on June 30, 2005.

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.